angelan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The clinical efficacy of dendritic cell (DC) vaccine in cancer patients has been unsatisfactory due, at least in part, to the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Angelan isolated from Angelica gigas Nakai inhibits tumor growth and metastasis by enhancing immune functions of macrophages… (More)
Is this relevant?
2007
2007
During the evolution of neoplastic diseases, dendritic cell (DC) functions are usually attenuated, and this presents a problem to… (More)
Is this relevant?
2006
2006
The pectic polysaccharide (angelan) of Angelica gigas Nakai is an immunostimulator that activates the immune functions of B cells… (More)
Is this relevant?
2001
2001
In our previous studies, we showed that angelan, a polysaccharide purified from Angelica gigas Nakai, specifically activated… (More)
Is this relevant?
2001
2001
In our previous studies, we showed that angelan, a polysaccharide purified from Angelica gigas Nakai, activated macrophages to… (More)
Is this relevant?
2000
2000
In our previous studies, we showed that angelan, a polysaccharide purified from Angelica gigas Nakai, is a potent LPS-mimetic in… (More)
Is this relevant?
1999
1999
In our previous studies we showed that the primary target cell of angelan, a polysaccharide purified from Angelica gigas Nakai… (More)
Is this relevant?
1999
1999
In our previous studies we showed that the primary target cell of angelan, a polysaccharide purified from Angelica gigas Nakai… (More)
Is this relevant?
1998
1998
The immunopharmacological characteristics of angelan, a polysaccharide purified from Angelica gigas Nakai, were investigated in… (More)
Is this relevant?